Does your insurance adviser really ‘get’ what you do you? If you operate in the healthcare, life sciences, biotech, R&D, medical device, pharma, or technology sectors, the insurance advice you need is far from standard – It is specialist and requires expert advice. As a member of OBN, our specialist life science and technology team is here to help you.
Specialist insurance & risk management advice for OBN members
If your company is involved in medical research programmes, clinical trials insurance will be vital – and a necessity. It’s designed to provide protection for your participants as well as your business should something go wrong.
Attracting & retaining a qualified team
In today’s challenging climate, attracting and retaining talent is proving harder than ever – particularly in specialist and niche sectors such as pharma and biotech industries. Creating an environment that optimises the wellbeing and engagement of your team can help maximise performance and protect your greatest asset – your people.
Key Person cover
The brains behind the science can be your most valuable asset – and one that your business needs to protect. Investors will usually insist on key person cover being in place for the key individuals before committing vital funding.
Why do you need specialist insurance?
From IP to IPO, Partners& can help you protect your business.
We’re able to deliver smart, flexible, high-performance insurance and risk management solutions – with a friendly human approach. From start-ups and spin-outs to companies with global operations, we can tailor a bespoke package to meet the challenges your business faces.
With offices across the UK, we are well placed to meet your needs wherever you are located, from spin-outs and start-ups to companies with global operations.
Our wealth of experience and focus on risk management advice has earned Partners& a reputation as one of the leading science and technology insurance brokers in the United Kingdom.
Start-ups & spin-outs
Biotech and bioscience companies
Research & Development (R&D)
Medical devices, medtech & healthtech
Usual types of cover
Insurance risks facing the life science and technology sector or wide-reaching and unique. From requirements from investors to secure funding, vital clinical trials, the rapid Covid-fuelled digitisation of healthcare and the “war for talent”, insurance is just a part of managing risk in the life science sector.
We offer OBN members a no-cost, no-obligation review of your current risk management and insurance programme.
Providing cover for your business contents, laboratory equipment, computers and work in progress.
Protection for loss of research expenditure or increased costs of working following loss or damage to your business assets.
Employers Liability is a statutory requirement and covers both your legal defence costs and legal liability to pay compensation to employees injured at work. Public Liability covers both your legal defence costs and your legal liability to pay compensation to third parties for bodily injury or damage to their property.
For companies involved in medical research, medical devices or drug discovery, clinical trials insurance is an essential part of your risk management package
Clinical trials liability insurance covers bodily injury (subject to policy terms/conditions) to a research subject due to their participation in a clinical trial.
Directors, company officers and senior managers can be held personally liable for the actions and decisions they make on behalf of the company. D&O can provide cover for legal advice and cover defence costs as well as any compensation costs that arise from an unsuccessful defence.
Intellectual property is an intangible business asset that often helps set companies apart from their competitors. Unfortunately, few businesses know precisely what their IP is worth, or how to protect it. IP insurance provides cover for claims alleging infringement of IP rights, including patents, trademarks, copyright and trade secrets.
Key Person insurance protects against the loss of profits that could result from the critical illness or death of a key individual (often a director or the brains behind the business), by paying out a cash sum so that the business can continue to operate.